Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-02

Clinical Trial Update: Safety and Efficacy of Infliximab in Palmoplantar Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial results report safety and efficacy of infliximab in palmoplantar psoriasis, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Palmoplantar Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-09-02